Market research
APH.LSE Alliance Pharma plc
LSE GBP Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 350M
- P/E ratio
- Not available
- Analyst target
- 63.1
- Dividend yield
- Not available
- Beta
- 0.58
Community
Investor discussion
1 comment
Sign in to join the APH.LSE discussion.
5 years, 5 months ago
Alliance Pharma plc is currently in a long term uptrend where the price is trading 16.7% above its 200 day moving average.
From a valuation standpoint, the stock is 99.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.9.
Finally, its free cash flow grew by 36.9% to $12M since the same quarter in the previous year.
Based on the above factors, Alliance Pharma plc gets an overall score of 3/5.